Association between prostate-specific antigen decline and survival outcomes in patients with metastatic castrate-resistant prostate cancer treated with first line abiraterone acetate

Autor:	L. Leal da Costa, J. Albuquerque, R. Vicente, D. Silva, C. Baptista, R. Bizarro, J. Moreira-Pinto, J. Godinho, F. Branco, A. Faria, F. Lopes, J.A. Teixeira
Rok vydání:	2022
Předmět:	Urology
Zdroj:	European Urology Open Science. 45:S164
ISSN:	2666-1683
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::929e28a2b8ae080244ceefde18791d5b https://doi.org/10.1016/s2666-1683(22)02531-9 Zobrazit plný text záznamu